Clinical Trial: Flotufolastat F 18 PET in Men with Very Low PSA Recurrence

U.S., March 7 -- ClinicalTrials.gov registry received information related to the study (NCT06862856) titled 'Flotufolastat F 18 PET in Men with Very Low PSA Recurrence' on Feb. 20.

Brief Summary: The purpose of this study is to assess detection rate of flotufolastat F 18 positron emission tomography (PET) for low prostate specific antigen (PSA) recurrence of prostate cancer (PC) following radical prostatectomy.

Study Start Date: May 20

Study Type: OBSERVATIONAL

Condition: Prostate Cancer (Adenocarcinoma) Prostate Specific Antigen

Intervention: DIAGNOSTIC_TEST: Positron Emission Tomography (PET)

This is a PET scan with flotufolastat F 18 injection.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Massachusetts General Hospital

Info...